Singular Genomics Systems is a life science technology company that is utilizing next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians. Co. has developed a proprietary NGS technology, which it refers to as its Sequencing Engine. Co.'s primary product, the G4, targets the NGS market and is comprised of an instrument and associated menu of consumable kits. Co.'s second product in development, the PX, combines single-cell analysis, spatial analysis, genomics and proteomics in one integrated instrument to provide a versatile multiomics solution. We show 12 historical shares outstanding datapoints in our OMIC shares outstanding history coverage, used to compute OMIC market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing OMIC market cap history over the course of time is important for investors
interested in comparing OMIC's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of OMIC versus a peer is one thing; comparing
OMIC market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like OMIC can fluctuate over the course of history.
With this page we aim to empower investors researching OMIC by allowing them to research the OMIC market cap history. |
Free OMIC Email Alerts:
Video: The Importance of Market Cap
